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Objectives: to examine possible involvement of several candidate genes in the aetiology of familial abdominal aortic
aneurysm (AAA).
Design: after reviewing the literature on the genetics of familial AAA, betaine homocysteine methyltransferase (BHMT),
collagen type Ia2 (COL1A2) and cathepsin H (CTSH), were selected as potential candidate genes, which influence
structure, strength, elasticity and mechanical resistance of the aortic wall.
Materials: forty-eight families with 110 family members and AAA were included in the affected sib-pair analysis. One
large family of three generations was analysed separately because in this family also other clinical symptoms were involved.
Methods: genetic linkage analysis was performed with DNA markers in the region of BHMT, COL1A2 and CTSH.
Results: In the overall sib-pair analysis, the LOD scores for BHMT, COL1A2 and CTSH were 0.7, 0.2 and ÿ0.7, whereas
in the large family these numbers were ÿ0.6, ÿ2.2 and ÿ2.7, respectively.
Conclusions: none of the candidate genes selected showed a suggestive linkage with AAA. Exclusion of the COL1A2 and
CTSH genes was possible in the large family that was analysed separately.
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Introduction
Despite evidence indicating a familial predisposition
to abdominal aortic aneurysm (AAA),1±4 it appears
difficult to identify the specific genes involved.
Recently, we have reviewed the genetic background
of familial AAA.5 Guo et al.6 performed linkage analy-
sis in patients with familial thoracic aortic aneurysms
(TAA). A major locus for familial TAA mapped to
chromosome 5q13-14. The betaine-homocysteine
methyltransferase (BHMT) gene is localised here and
might be a possible candidate gene. BHMT catalyses
the conversion of betaine and homocysteine to dimethyl-
glycine and methionine. Hyperhomocysteinaemia is a
risk factor for arterial occlusive disease, but probably
also for aneurysmal disease.7±10 Vouyouka et al.11
demonstrated a significant weakening of the aortic
wall in collagen type Ia2 (COL1A2) knock-out mice.
The integral role of COL1A2 in the biomechanical
and functional properties of the aorta might help to
elucidate the role of collagen in the development of
aneurysmal aortic disease. Tung et al.12 found a
30-fold upregulation of cathepsin H (CTSH) in the
aneurysmal wall of the abdominal aorta, using a com-
mercially available membrane-based complementary
DNA expression array. Increased activity of cathepsin
H, which is a cysteine- dependent protease, can medi-
ate extensive matrix breakdown, thereby negatively
influencing the elasticity and mechanical resistance
of the aortic wall. The aim of this study was to per-
form genetic linkage analysis of betaine homocysteine
methyltransferase, collagen type Ia2 and cathepsin H
in patients with familial AAA.
Materials and Methods
Subjects and family collection
Computerised records containing diagnostic codes for
the years 1996±2001 of 12 hospitals, with a department
of vascular surgery, in the north-west region of the
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Netherlands were searched for patients diagnosed
with, infrarenal abdominal aortic aneurysm with or
without rupture (ICD codes 4413(-02), 4414(-02)). An
AAA was defined as an aortic diameter greater
than 3 cm in the infrarenal portion of the aorta, or a
diameter of 50% greater than the normal suprarenal
aorta.13 A total of 766 AAA patients complied with these
diagnostic criteria. These patients received a letter,
asking for information about their family history. A
positive family history for AAA was defined as one or
more first-degree relatives (FDRs) with an AAA.
Patients with the Ehlers Danlos syndrome type IV
were excluded. There was a 91.6% response rate after
one recall letter and 81 persons claimed to have one
or more FDRs with an AAA. Forty eight persons, 44
males and four females (index cases), with 53 brothers
and nine sisters were able to participate in the study.
One AAA patient with one affected FDR is called an
affected sib-pair (Flow diagram and Table 1). One
large family of three generations was analysed separ-
ately because of additional clinical symptoms other
than AAA, including bruises, skin hyperextensibility
and joint hypermobility (Fig. 1). Previously, linkage to
collagen type III and V, fibrillin 1 and elastin had
been excluded in this family. Subsequently, the medical
records for the index patients and their relatives were
Table 1. Number of affected relatives and the number of sib-pairs
in AAA families include in the study.
Affecteds N Families N Sib-pairs N
5 1 10
4 2 12
3 7 21
2 38 38
Total 48 81
Number of sib-pairs per family: 2 affecteds 1, 3 affecteds 3,
4 affecteds 6, 5 affecteds 10 sib-pair(s).
Flow diagram. An AAA was defined as an aortic diameter greater
than 3 cm in the infrarenal portion of the aorta, or a diameter of 50%
greater than the normal suprarenal aorta.13 yThe patients with one
or more first-degree relative (FDR). zAn AAA patient with one
affected FDR is called an affected sib-pair. See Table 1.
Fig. 1. The figure shows the family tree of the large family with abdominal aortic aneurysms (AAA) and other symptoms. Filled squares and
circles of the upper left indicates those in whom AAA was diagnosed, filled squares and circles of the upper right indicates those in whom
bruises was diagnosed, filled squares and circles of the lower left indicates those in whom joint hypermobility was diagnosed, filled squares
and circles of the lower right indicates those in whom skin hyperextensibility was diagnosed. All other individuals are not known to be
affected and are treated as unknown in the analysis. I±IIIdifferent generations and year of birth. Individual II-8 died of a ruptured AAA at
the age of 30 years. Addition symptoms: II-3 pulmonary aneurysm and tricuspid valve regurgitation; II-2 varicosis.
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reviewed and the diagnoses verified. We invited the
index patients and their relatives for recording of the
medical and family history and the collection of blood
samples for DNA analyses. These studies were
approved by the local ethics committee and all
patients and their family members gave informed
consent.
Material
DNA was extracted from peripheral blood, using
DNAzol reagent (Invitrogen, Molecular Research
Center, Inc., Cincinnati, OH, U.S.A.). Variable number
tandem repeats (VNTRs) markers analysed in the
BHMT region were D5S646 and D5S2029, for
COL1A2 D7S1799, D7S527 and D7S657 and for CTSH
D15S153, D15S653, D15S973 and D15S1023. Fluores-
cent labelled primers were customade by Invitrogen.
Average heterozygosity of the markers is present in
66±87% of CEPH families. For 25 ml polymerase chain
reaction (PCR) mix we used 100 ng DNA, 1.5 mM
MgCl2, 200 mM dNTP's and 10 picomoles primers. A
control sample was derived of CEPH1347-02 DNA
(www.ceph.fr). The PCR conditions (Perkin Elmer 9600)
used were 94 C for 2 min to activate the platinum
Tag-polymerase, 35 cycles of denaturation at 94 C
for 1 min, annealing at 59±57±55 C for respectively
5±5±25 cycles and elongation at 72 C for 1 min. The
pooled products were supplemented with an internal
size standard and fragment analysis was performed
on an ABI PRISM 310 Genetic Analyser (Applied
Biosystems, Torrance, CA, U.S.A.).
Statistical analysis
Linkage analysis is most often used to localise a dis-
ease gene by virtue of its linkage to a genetic marker
locus on the gene map. Linkage of a disease pheno-
type and a marker means that two are located closely
on the same physical piece of DNA. The closer two
loci occur on a piece of DNA, the less frequent cross-
overs are and the more tightly the two are linked. The
linkage between the disease phenotype and the mark-
er can be expressed as a distance in genetic map
units (centimorgan; cM). Linkage can be established
whenever the phenotype and genotype of related
individuals is analysed, therefore linkage can be
established by analysing large families or by analysing
pairs of siblings.14,15 For diseases with a known
Mendelian mode of inheritance, the appropriate tech-
nique is the parametric LOD score (maximum likeli-
hood) approach. The non-parametric affected sib-pair
approach, does not require any assumption on mode
of inheritance and only looks for deviations in the
inheritance of marker alleles from parent to affected
offspring. Many non-parametric approaches estimate
identity by descent (IBD) allele sharing by maximum
likelihood and then present results in terms of LOD
scores. Both approaches may be applied with the aid
of computer programs. This typically results in a
`` LOD score curve'' along the chromosome whose
maximum identifies the estimated position of the
disease locus and whose magnitude is indicative of
the strength of linkage.16
Affected sib-pair analyses were performed using
the Allegro version 1.1 computer program for multi-
point genetic linkage analysis.17 The null-hypothesis
of this analysis, assuming no linkage between the
disease and tested markers, is that 25% of siblings
share zero alleles, 50% share one allele and 25%
share two alleles for each marker. Positive linkage
between a marker and disease, irrespective of the
mode of inheritance, will be reflected by a deviation
from these proportions with an excess of allele shar-
ing. Results are given as non-parametric multipoint
LOD scores. The LOD score in allele sharing analyses
is the base 10 logarithm of the ratio between the like-
lihood that observed excess allele sharing that is based
on linkage between a marker and the disease and the
likelihood that the excess sharing occurred by chance.
A LOD score above 3.0 is considered significant for
linkage.18 The term `` multipoint'' means that informa-
tion of all markers for one candidate gene was used
simultaneously. In sib-pair analyses a LOD score
lower than ÿ2 is considered significant evidence for
exclusion of linkage.19 The Mega 2 version 2.3 data
conversion program and SimWalk2 version 2.82 statis-
tical genetics computer program for Windows were
used to analyse the large family.20,21 The linkage
analysis was performed parametric, assuming an
autosomal dominant inheritance with reduced pene-
trance as the genetic model (Fig. 1). The prevalence of
patients with the same clinical symptoms in the whole
population was assumed to be 0.01% and the pene-
trance of mutant genes was set at 80% with dominant
inheritance. All individuals not known to be affected
were classified as `` unknown''.
Results
Clinical characteristics of classical risk factors like
smoking habits, the presence of hypertension (WHO
criteria), diabetes mellitus and hypercholesterolaemia
(all investigated by a physician), and atherosclerotic
manifestations such as peripheral, coronary and
Familial Aortic Aneurysm 207
Eur J Vasc Endovasc Surg Vol 26, August 2003
cerebral arterial occlusive disease were not signifi-
cantly different compared with AAA patients with-
out familial AAA (unpublished data), as earlier
described.22 Results of the sib-pair and large family
genetic linkage analyses are shown in Figure 2. The
maximal simulated LOD scores calculated, assuming
the presence of linkage, for the siblings and large
family were 8.6 and 4.4, respectively. We estimated
the position of the candidate gene compared to the
position of the DNA markers in the genomic DNA
sequence (www.ncbi.nlm.gov.entrez/nucleotide). The
positions are indicated with a vertical line in Figure 2.
The exact relative positions in cM are not known, but
it is assumed that no large differences in recombin-
ation frequencies exist within the small regions
between the markers. The LOD scores at the position
of the candidate genes were in the sib-pair analyses
were 0.7, 0.2 and ÿ0.7 at the locations of the BHMT,
COL1A2 and CTSH genes, respectively. In the large
family, the LOD scores were ÿ0.6, ÿ2.2 and ÿ2.7,
respectively. In the large family, the genes for
COL1A2 and CTSH could be excluded as a possible
candidate gene. None of the other tested genes could
be proven or excluded as a possible candidate because
of the low positive and negative LOD scores.
Discussion
Genetic linkage analysis is a technique for measuring
the genetic distance between two loci on a chromo-
some. Alleles at loci in close proximity with each other
will be co-inherited as a `` package'' (haplotype) from
parents to offspring.16 Particularly, linkage in a large
family, with several generations and large offspring, it
will be expected that the same gene(s) is/are respon-
sible for the disease. Linkage analysis of regions
containing the genes BHMT, COL1A2 and CTSH was
chosen after a systematic research of the literature.5We
found no evidence of linkage of the candidate genes
BHMT, COL1A2 and CTSH for familial AAA. None of
the regions attained a LOD score higher than 3.0.
Linkage was excluded in the large family for the
COL1A2 and CTSH genes. Linkage could not be
excluded for the other regions with low positive or
negative LOD scores listed above and none of the
results showed a suggestive linkage with AAA.
BHMT, next to methionine synthase, serves as a facili-
tator of methyl group donation for remethylation of
homocysteine into methionine and reduced function-
ing of BHMT could theoretically result in elevated
homocysteine levels. The actual events that cause
Fig. 2. Results of linkage analysis of DNA markers in the region of betaine homocysteine methyltransferase (BHMT), collagen type1a2
(COL1A2) and cathepsin H (CTSH) in siblings with abdominal aortic aneurysms (AAA) and in a large family of three generations with AAA
and other symptoms (see Fig. 1). Each box represents the results of the candidate gene, the y-axis depicts the multipoint LOD score, the
x-axis the cM distance of the markers used. The vertical line is an estimation of the position of the candidate gene compared to the DNA
markers.
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aneurysmal degeneration and their relation to
atherosclerosis are unsolved. Arteriosclerosis is pre-
dominantly a disease of the intima whereas AAA
involves a transmural degenerative process. A pos-
sible explanation can be found in the induction of
elastolysis by homocysteine in arterial media through
the activation of matrix metalloproteinase-2 (MMP-2),
demonstrated in an animal model.23 Although ele-
vated homocysteine levels have been associated with
arteriosclerosis and aneurysmal disease8,10,24 our
results provide no evidence for linkage of BHMT
with AAA. Seventy percent of the extracellular matrix
of the abdominal aortic wall consists of collagen, pro-
viding the integrity to withstand the outward forces
exerted by arterial pressure. More than 150 different
mutations have been reported in the genes for procol-
lagen type I (COL1A1 and COL1A2). Mutations in
COL1A2 cause heritable disorders of connective tis-
sue, i.e. osteogenesis imperfecta type II (OI, brittle
bone syndrome) and Ehlers Danlos Syndrome type
VII (EDS VII, characterised by excessive joint hyper-
mobility and skin abnormalities).25 Mutations in pro-
collagen type I do not have important influence on the
vascular integrity that might contribute to aneurysmal
degeneration. In contrast, Vouyaka et al.11 showed in a
mouse model that absence of collagen type 1a2 weak-
ens the thoracic aorta. They demonstrated an integral
role of collagen type 1a2 in the biomechanical and
functional properties of the aorta. As mentioned
above, the abdominal aorta consists of a higher per-
centage of collagen and alterations of collagen type
1a2 could have even more influence on the tensile
strength of the aortic wall and in this way contribute
to aneurysm formation. In the large family, but not in
the sib-pair analysis, linkage to COL1A2 was
excluded. The cathepsins comprise a group of intra-
cellular proteases. Lysosomal proteases, i.e. cathepsins
D, H and L, are involved in the degradation of struc-
tural proteins and were found to have higher activities
in the aneurysmal wall and a mural thrombus than in
the normal aortic wall.12,26 The elastic and mechanical
properties of the aorta can be negatively influenced by
matrix breakdown due to cathepsin. Linkage to the
region of CTSH was excluded in the large family, but
not in the sib-pair group due to low negative LOD
scores. Familial AAA is well documented, but the
genetic aetiology remains unclear. Our study indicates
no linkage of BHMT, COL1A2 or CTSH genes. Pos-
sible other candidate genes, which have influence on
the degradation of the aortic wall, are the proteinases,
i.e. matrix metalloproteinases, plasminogen activa-
tors, serine elastases and other cysteine proteases.
The influence of inflammation and immune responses
on the destruction of the aortic wall is also of subject
for further investigation.27 In the future we expect that
genome-wide scans can identify susceptible loci. If
loci are found, new candidate genes will be identified.
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